Celcuity (CELC) Cash from Investing Activities (2016 - 2025)
Celcuity (CELC) posted Cash from Investing Activities of $103.4 million for Q4 2025, up 140.14% on a QoQ basis from -$257.6 million in Q3 2025, and up 175.32% year-over-year from $37.6 million in Q4 2024.
Celcuity (CELC) Cash from Investing Activities (2016 - 2025) Analysis & Trends
Celcuity's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $103.4 million for Q4 2025.
- Quarterly Cash from Investing Activities rose 175.32% year-over-year to $103.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$64.1 million (down 1.61% YoY) and the FY2025 annual result came in at -$64.1 million, down 1.61% from the prior year.
- Cash from Investing Activities was $103.4 million for Q4 2025 at Celcuity, up from -$257.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $103.4 million in Q4 2025 and bottomed at -$257.6 million in Q3 2025.
- A 5-year average of -$13.8 million and a median of -$10787.0 in 2021 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 1448587.69% — and 2023, when it jumped 188046.29%.
- Celcuity's Cash from Investing Activities stood at -$9939.0 in 2021, then tumbled by 1448587.69% to -$144.0 million in 2022, then jumped by 71.37% to -$41.2 million in 2023, then soared by 191.12% to $37.6 million in 2024, then soared by 175.32% to $103.4 million in 2025.
- Business Quant data shows CELC's Cash from Investing Activities at $103.4 million in Q4 2025, -$257.6 million in Q3 2025, and $65.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -45.51 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 178,242.27 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 172.62 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 103.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103.41 Mn |
| Dec 31, 2025 | 103.41 Mn |
| Sep 30, 2025 | -257.61 Mn |
| Sep 30, 2025 | -257.61 Mn |
| Jun 30, 2025 | 65.86 Mn |
| Jun 30, 2025 | 65.86 Mn |
| Mar 31, 2025 | 24.26 Mn |
| Mar 31, 2025 | 24.26 Mn |
| Dec 31, 2024 | 37.56 Mn |
| Dec 31, 2024 | 37.56 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | -106.07 Mn |
| Jun 30, 2024 | -106.07 Mn |
| Mar 31, 2024 | 3.54 Mn |
| Mar 31, 2024 | 3.54 Mn |
| Dec 31, 2023 | -41.22 Mn |
| Dec 31, 2023 | -41.22 Mn |
| Sep 30, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.25 Mn |